INVESTORS IN LIFE SCIENCES
The Bio/Med Investor Network was established in 2014 to address the need to connect early-stage biomedical, medtech and healthcare-related companies with angel investors interested in advancing technologies in this innovative industry. The majority of our investors specialize in life sciences, and include active and retired executives, practicing physicians, and scientists. Their unique qualifications guide screening and due diligence to help fellow members choose their investments.
OcuCure is an ophthalmic pharmaceutical company developing new proprietary compounds with a focus on topical eye drops.
Mana Health is dedicated to streamlining data access, interoperability, and innovation in healthcare.
New York, NY
Fortus' proprietary technology is used to harvest a patient's own mesenchymal stem cells (MSCs) leaving a highly concentrated stem cell solution, which is combined with bone graft material to repair and promote new bone growth in a patient.
c/o Erris Consulting Group
1201 Peachtree St. NE, Suite 300 | Atlanta, GA 30361